BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 156.1% in February

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 10,500 shares, an increase of 156.1% from the January 31st total of 4,100 shares. Based on an average trading volume of 32,100 shares, the days-to-cover ratio is currently 0.3 days.

BioNxt Solutions Price Performance

OTCMKTS BNXTF remained flat at $0.35 on Friday. 15 shares of the company’s stock traded hands, compared to its average volume of 10,361. BioNxt Solutions has a 1 year low of $0.11 and a 1 year high of $0.49. The stock has a market capitalization of $39.66 million, a P/E ratio of -8.74 and a beta of 0.69. The business has a 50 day simple moving average of $0.29 and a two-hundred day simple moving average of $0.22.

BioNxt Solutions (OTCMKTS:BNXTF) last posted its earnings results on Friday, November 29th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About BioNxt Solutions

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.